Rick Renckens
About Rick Renckens
Rick Renckens is the Regional Sales Manager at Boston Scientific, with a career spanning various roles in the medical sales industry since 2000. He has a proven track record in sales performance and leadership, particularly in prostate health and minimally invasive procedures.
Current Role at Boston Scientific
Rick Renckens has been a Regional Sales Manager at Boston Scientific since 2018. He operates in the Greater Minneapolis-St. Paul Area. In this role, he leads a rapidly growing Prostate Health team across multiple states including Minnesota, Western Wisconsin, North Dakota, South Dakota, Iowa, Nebraska, and Kansas.
Previous Experience at Nuvectra and CR Bard
Before joining Boston Scientific, Renckens worked at Nuvectra as a Territory Manager from 2016 to 2018 in the Greater Minneapolis-St. Paul Area. Prior to Nuvectra, he served as a Vascular Territory Manager at CR Bard for five years, covering Minnesota and North Dakota from 2011 to 2016.
Early Career and Roles at Smith & Nephew, Shire, and Popp Communications
Rick Renckens’ career includes positions as Trauma Sales Consultant at Smith & Nephew from 2009 to 2011, and as Senior Professional Sales Representative at Shire from 2004 to 2009. He also worked as a Sales Consultant at Popp Communications from 2000 to 2004.
Educational Background
Rick Renckens studied Business Marketing at the University of St. Thomas from 1996 to 2000, earning a degree in Business. He also attended Augsburg University for one year from 1995 to 1996, and completed his high school education at Benilde St. Margaret's from 1991 to 1995.
Sales Performance and Achievements
Rick Renckens has a documented track record of success in sales. He has won six President's Club awards for outstanding sales performance. Renckens is known for his expertise in driving the adoption of new technology and healthcare economics. His focus includes integrating minimally invasive procedures in physician's offices, thereby improving the quality of life for men diagnosed with BPH and prostate cancer.